Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Viktor Kharitonin

Viktor Kharitonin

Viktor Kharitonin (#506)

Global Rank #506
Country Rank #23
Country Russia

Viktor Kharitonin is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 8 B
  • Pharmaceuticals
  • Russia
  • M
  • 53 Years

Snapshot

Quick Facts

Global Rank #506
Country Rank #23
Net Worth $7.9B
Previous Worth $7.9B
Worth Change +$0.0B
Country Russia
Industry Pharmaceuticals
Age 53 Years
Gender M
Worth As Of April 26, 2026
Last Refreshed 08 Sep 2026, 12:00 AM
Residence Moscow, Russia
World Billionaires List Russia Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 53
Source Of Wealth Pharmaceuticals, Self Made
Residence Moscow, Russia
Citizenship Russia
Marital Status Married
Children 2
Education Master of Science, Novosibirsk State University
Net Worth Change +$0.0B +0.0% from previous worth
Previous Net Worth $7.9B
Current Net Worth $7.9B

Worth as of April 26, 2026

About Me

Viktor Kharitonin created multinational pharmaceutical firm Pharmstandard with Russian billionaire Roman Abramovich and other partners in 2003 by combining five factories. Kharitonin and partner Egor Kulkov bought out the other investors in 2008, a year after Pharmstandard went public in London. They took Pharmstandard private again, eight years later. Kharitonin and Kulkov also hold stakes in other Russian pharmaceuticals companies: OTCPharm, Biocad and Generium, one of the producers of the COVID-19 vaccine Sputnik V. In 2022 The two partners tried to buy Russian assets of Austrian-British packaging and paper group Mondi for 1.5 billion euro, but Russian authorities rejected the deal. In 2023 Kharitonin and his partners bought Russian assets of German chemical producer Henkel for 600 million euros, leaving Henkel the option of buying back the business.

Insights

Did You Know?

In October 2014 Kharitonin became co-owner of Nurbugring in Germany, one of the oldest race tracks in Europe.

The Novosibirsk State University graduate got his start selling consumer goods.

Wealth Growth

Net Worth Growth Over Time

Tracking Viktor Kharitonin's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $7.9B (April 26, 2026)

© Iconic Billionaires